Bella, Joel B.
HRN: 06-90-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
CEFUROXIME 1.5GM (VIAL)
04/29/2022
05/06/2022
IVT
1.5g
Q8
Wound Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes